跳至主要内容
临床试验/NCT05785689
NCT05785689尚未招募4 期

Autonomous Nervous System Regulated Anaesthesia: A Randomized Controlled Trial Comparing Dexmedetomidine and Placebo in Heart Rate Variability Monitored Children

University of Southern Denmark1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2023年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
220
试验地点
1
主要终点
Richmond Agitation Sedation Scale Score (RASS)

研究概览

简要总结

The goal of this randomized, double blinded study is to examine in children whether postoperative agitation can be reduced.

The main question it aims to answer is Will optimized, monitor guided analgesic treatment and dexmedetomidine reduce postoperative agitation Participants will receive a standard anaesthesia regimen and on top of that, a titrable remifentanil infusion guided via Mdoloris Anastasia nociception index (ANI) monitor will be added. Additionally, the patients will receive either bolus placebo or bolus dexmedetomidine. The postoperative agitation measured via the Richmond agitation and sedation scale (RASS) score, will be compared. Secondary outcome measures including carbon dioxide trends will be made.

详细描述

Study protocol

Screening of eligible patients before procedure day All children assigned for evaluation for abdominal or urology procedures are primarily seen by surgeons in an ambulatory visit. This takes place in the months or weeks before surgery. If surgery for abdominal or urology issues is decided, the paediatric surgeons hand out a patient s folder about the present study. The patient information folder is seen in supplement 1. Line Gry Larsen (LGL) will attend the surgeon's ambulatory visits in the start-up phase, assisting the paediatric surgeons in what information to give by handing out patient information folders. It is not the intent that the paediatric surgeons should give the full information. If the parents/legal representative(s) consent to further contact, they sign a brief consent form for primary contact, including the preferred phone number and time frame, see supplement 2 The parents are then contacted by phone by one of the researchers within the assigned time frame, and the study is now introduced in full, in line with the information given in the patient information folder. There will be time for questions and careful consideration about participation. The researchers who provide the information to the families are all experienced within the field of anaesthesia, research, and Good Clinical Practice (GCP)-guidelines. If the parents show immediate interest in participating, the importance of bringing a signed power of attorney if one of the parents/legal representatives is not attending on the procedure day is emphasized.

Progress on procedure day

Information, consent, and randomization On the procedure day, one of the researchers again consults with the child and its parents/legal representatives in a private meeting room. They are offered the possibility to bring a bystander or be provided one. A summary of information about the study previously given by phone is done, including the right to withdraw consent. Questions are again encouraged. If the parents/legal representatives after receiving oral and written information agree on participation, consent forms are now signed and randomization is done to either placebo or intervention group, blinded for the participant, researcher, and other staff. The procedure is then performed that same day. Contact information is stored in the REDCap database for follow-up data, and to provide the family conclusions of the study after finalization.

Anaesthesia One or both parents or legal representatives follow the child to the operating theatre. Induction of anaesthesia is set as time = 0 and the first RASS score is registered. The child is then anaesthetized via inhalation of sevoflurane 8% on a mask while she or he is sitting with one of the parents. As soon as the child is asleep, the parents are shown to a waiting area. I.v access is obtained, and fentanyl 2-4 mcg i.v is given, and adjusted to fit the planned procedure. Airway management is typically done with a laryngeal mask aiming to keep the child spontaneous breathing throughout the procedure. Standard monitoring is applied: ECG, blood pressure cuff measuring, and fingertip oxygen saturation. Furthermore, all children are ANI monitored. A continuous infusion of remifentanil 0,5 mcg/kg/hour is started immediately and withheld for the entire procedure. Sevoflurane concentrations, airway pressure, and end-tidal carbon dioxide tensions, are noted. When all monitoring equipment is applied, a bolus infusion of the study drug (dexmedetomidine 0,5 mcg/kg or placebo) is given within the first 10 minutes. With ANI values < 50, a bolus of fentanyl of 1 mcg/kg or remifentanil 0,1 mcg/kg is given. Which drug is given, is assessed, and decided by the anaesthetist. The effect of this intervention is evaluated every five minutes and repeated if ANI is still < 50. Sevoflurane concentration is adjusted, guided by a clinical evaluation in a usual manner, guided by Minimum Alveolar Concentration (MAC) values 0,7-1,4. In the case of bradycardia or other arrhythmias, bolus dexmedetomidine (DEX) is immediately discontinued, and remifentanil (REMI) is withheld until baseline heart frequency is achieved. If longer-lasting bradycardia exists, iv. Atropine/kg bodyweight is given. To connect specific events to ANI values, the following are registered via the monitor: "infusions", "airway in", "incision", "bolus remifentanil", "bolus fentanyl", "neuraxial", "local anaesthesia", "bolus sevoflurane", "suture"," intense surgical stimuli"," bradycardia", "other [note in anaesthesia chart]", and "airway out".

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
1 Year 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Missing consent from both parents/legal representatives.
  • Known allergies or intolerances for remifentanil and dexmedetomidine.
  • Intubation.
  • Non fluently Danish speaking/reading parents/representatives

研究组 & 干预措施

DEX: Bolus dexmedetomidine 0,5 mcg/kg

Experimental

Intravenous infusion during first 10 minutes of anesthesia

干预措施: Dexmedetomidine (Drug)

Placebo (PCB): Bolus isotonic saline

Placebo Comparator

Intravenous infusion during first 10 minutes of anesthesia

干预措施: Placebo (Drug)

结局指标

主要结局

Richmond Agitation Sedation Scale Score (RASS)

时间窗: Every 15. minutes while admitted to postoperative care unit (PACU) and until discharge, within a time frame of maximum 240 minutes

Nurse evaluation of agitation/sedation on a scale from -5 (deeply sedated) to +4 (highly agitated)

次要结局

  • Anaesthesia time consumption(From the minute of induction of anaesthesia minute of extubation, within a time phrame of 180 minutes)
  • Postoperative care unit (PACU) time consumption(From the minute of entering PACU area to the minute of discharge from hospital, within a time phrame of 400 minutes)
  • Total time consumption(From the minute of induction of anaesthesia to the minute discharge from hospital, within a time phame of 600 minutes)
  • Total fentanyl dosage(From the minute of induction of anaesthesia to the minute discharge from hospital, within a time phame of 600 minutes)
  • total remifentanil dosage(From the minute of induction of anaesthesia to the minute discharge from hospital, within a time phame of 600 minutes)
  • Postoperative Nausea and vomiting (PONV) in Postoperative Care Unit (PACU)(From the minute of entering the PACU area to the minute of discharge from hospital, time phrame of maximum 400 minutes)
  • Postoperative Nausea and vomiting (PONV) after discharge(From the minute of discharge from hospital until 24 hours after discharge from hospital. Time phrame of maximum 24 hours.)
  • Nurse - numeric Rating Score (nNRS)(From the minute of entering the PACU area to the minute of discharge from hospital, a time phrame of maximum 400 minutes)
  • Parent - Numeric Rating Scale (pNRS)(From the minute of discharge from hospital until 24 hours after discharge from hospital. Time phrame of maximum 24 hours.)
  • Face Leggs Agitation Cry Consolidation (FLACC) scale score(From the minute of entering the PACU area to the minute of discharge from hospital, a time phrame of maximum 400 minutes)
  • Paediatric Emergency Delirium Scale Score (PAED) scale score(From the minute of entering the PACU area to the minute of discharge from hospital, a time phrame of maximum 400 minutes)
  • Paracetamol dosage(From admission to hospital until 24 hours after anesthesia, maximum of two days)
  • Voltaren dosage(From admission to hospital until 24 hours after anesthesia, time phrame of maximum of two days)
  • Other analgesics dosage(From admission to hospital until 24 hours after anesthesia, time phrame of maximum of two days)
  • Propofol dosage(From the minute of induction of anaesthesia until care overtaken by postoperative care (PACU) nurses, within a time frame of 400 minutes)
  • events(During anaeshtesia between induction and extubation, within a time frame of maximum 400 minutes)
  • Carbondioxide tensions(Every five minutes during anaestesia, between induction and extubation, within a time phrame of maximum 400 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Line Gry Larsen

Principal Investigator

University of Southern Denmark

研究点 (1)

Loading locations...

相似试验

Autonomous Nervous System Regulated Paediatric... | 临床试验